The outcomes movement and new measures of the severity of psoriasis

Journal of the American Academy of Dermatology

Volumn 34, Issue 3, 1996, Pages 534-538

  McKenna, K E ^a   Stern, R S ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE SEVERITY; FOLLOW UP; HUMAN; PRIORITY JOURNAL; PROGNOSIS; PSORIASIS; QUALITY OF LIFE; REVIEW; TREATMENT OUTCOME;

EID: 0029913832     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(96)90469-7     Document Type: Article

References (47)

1. Jobling R. Psoriasis: a preliminary questionnaire study of sufferers' subjective experience. Clin Exp Dermatol 1976; 1:233-6.
2. Jowett S, Ryan T. Skin disease and handicap: an analysis of the impact of skin conditions. Soc Sci Med 1985;20: 425-9.
3. Ramsey B, O'Reagan M. A survey of the social and psychological effects of psoriasis. Br J Dermatol 1988;118:195-201.
4. Glickman FS. Lepra, psora, psoriasis. J AM ACAD DERMATOL 1986;14:863-6.
5. Updike J. Personal history: at war with my skin. The New Yorker 1985; Sep 2:39-57.
6. Potter D. The singing detective. London: Farber & Farber, Ltd., 1986.
7. Research needs in 11 major areas in dermatology. I. Psoriasis [Committee report]. J Invest Dermatol 1979;73:402-13.
8. Krueger GG, Bergstresser PR, Lowe NJ, et al. Psoriasis. J AM ACAD DERMATOL 1984;11(suppl):937-48.
9. Marks R, Barton SP, Shuttleworth D, et al. Assessment of disease progress in psoriasis. Arch Dermatol 1989;125:235-40.
10. Epstein AM. The outcomes movement: Will it get us where we want to go? N Engl J Med 1990;323:266-70.
11. Ellwood PM. Outcomes management: a technology of patient experience. N Engl J Med 1988;318:1549-56.
12. Relman AS. Assessment and accountability: the third revolution in medical care. N Engl J Med 1988;319: 1220-2.
13. Ware JE. The conceptualization and measurement of health for policy relevant research in medical care delivery (P-5599). Santa Monica, Calif.: Rand Corp, 1976.
14. Brook RH, Davies-Avery A, Greenfield A, et al. Assessing the quality of care using outcome methods: an overview of the method. Med Care 1977;15(suppl 9):S5-S15.
15. Hornquist JO. The concept quality of life. Scand J Soc Med 1982;10:57-61.
16. Patrick DL, Bergner M. Measurement of health status in the 1990s. Annu Rev Public Health 1990;11:165-83.
17. Revicki DA. Health-related quality of life in the evaluation of medical therapy for chronic illness. J Fam Pract 1989;29:377-80.
18. Likert R. A technique for the measurement of attitudes. Arch Psychol 1932;140:44-60.
19. Scott PJ, Huskisson EC. Measurement of functional capacity with visual analogue scales. Rheumatol Rehab 1977;16:257-9.
20. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989;27(suppl):S217-S32.
21. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993;118:622-9.
22. Meenan RF, Gertman PM, Mason JH. Measuring health status in arthritis: the Arthritis Impact Measurement Scales. Arthritis Rheum 1980;23:146-52.
23. MacKeigan LD, Pathak DS. Overview of health-related quality-of-life measures. Am J Hosp Pharm 1992;49:2236-45.
24. Bergner M, Bobbitt RA, Carter WB, et al. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981;29:787-805.
25. Blischke WR, Bush JW, Kaplan RM. Successive intervals analysis of preference measures in a health status index. Health Serv Res 1975;10:181-98.
26. Williams A. Quality adjusted life years and coronary artery bypass grafting. In: Department of Health and Social Services Publication on Quality Adjusted Life Years. London, UK: DHSS, 1985:75-88.
27. Stern RS, Armstrong RB, Anderson TF, et al. Effect of continued ultraviolet B phototherapy on the duration of remission of psoriasis: a randomized study. J AM ACAD DERMATOL 1986;15:546-52.
28. Lowe NJ, Weingarten D, Bourget T, et al. PUVA therapy for psoriasis: comparison of oral and bath-water delivery of 8-methoxypsoralen. J AM ACAD DERMATOL 1986;14:754-60.
29. Ramsey B, Lawrence CM. Measurement of involved surface area in patients with psoriasis. Br J Dermatol 1991; 124:565-70.
30. Fredriksson T, Pettersson U. Severe psoriasis: oral therapy with a new retinoid. Dermatologica 1978;157:238-44.
31. Van de Kerkhof PC. On the limitations of the psoriasis area and severity index (PASI). Br J Dermatol 1992;126:205.
32. Bahmer F. The size of lesions or point counting as a step toward the solution of the PASI problem. Arch Dermatol 1989;125:1282-3.
33. Lawrence CM, Howel D, Shuster S. Site variation in anthralin inflammation on forearm skin. Br J Dermatol 1986; 114:609-13.
34. Quinn AG, McLelland J, Essex T, et al. Measurement of cutaneous inflammatory reactions using a scanning laser-Doppler velocimeter. Br J Dermatol 1991;125:30-7.
35. Ginsburg IH, Link BG. Feelings of stigmatization in patients with psoriasis. J AM ACAD DERMATOL 1989;20:53-63.
36. McHenry PM, Doherty VR. Psoriasis: an audit of patients' views on the disease and its treatment. Br J Dermatol 1992; 127:13-7.
37. Committee on Rating of Mental and Physical Impairment. The skin. JAMA 1970;211:106-12.
38. Robinson HM. Measurement of impairment and disability in dermatology. Arch Dermatol 1973;108:207-9.
39. Leu RE. Economic evaluation of new drug therapies in terms of improved life quality. Soc Sci Med 1985;21:1153-61.
40. Wessely SC, Lewis GH. The classification of psychiatric morbidity in attenders at a dermatology clinic. Br J Psychiatry 1989;155:686-91.
41. Gupta MA, Gupta AK, Kirkby S, et al. A psychocutaneous profile of psoriasis patients who are stress reactors. Gen Hosp Psychiatry 1989;11:166-73.
42. Finlay AY, Kelly SE. Psoriasis: an index of disability. Clin Exp Dermatol 1987;12:8-11.
43. Finlay AY, Khan GK, Luscombe DK, et al. Validation of Sickness Impact Profile and Psoriasis Disability Index in psoriasis. Br J Dermatol 1990;123:751-6.
44. Salek MS, Finlay AY. Cyclosporin improved quality of life in psoriasis: Does this matter? [Abstract] Br J Dermatol 1993;129(suppl 42):32.
45. Root S, Kent G, Al-Abadie MSK. The relationship between disease severity, disability, and psychological distress in patients undergoing PUVA treatment for psoriasis. Dermatology 1994;189:234-7.
46. Baker DR. Prioritization of health services: the Oregon Basic Health Services Act and its implications for dermatologists and patients with dermatologic disease. Dermatol Clin 1993;11:241-9.
47. Gill TM, Feinstein AR. A critical appraisal of the quality of the quality-of-life measurements. JAMA 1994;272:619-24.